7Baggers
Quarterly
Annual
    Unit: USD2025-08-31 2025-05-31 2025-02-28 2024-11-30 2024-08-31 2024-05-31 2024-02-29 2023-11-30 2023-08-31 2023-05-31 2023-02-28 2022-11-30 2022-08-31 2022-05-31 2022-02-28 2021-11-30 2021-08-31 2021-05-31 2021-02-28 2020-11-30 2020-08-31 2020-05-31 2020-02-29 2019-11-30 2019-08-31 2019-05-31 2019-02-28 2018-11-30 2018-08-31 2018-05-31 2018-02-28 2017-11-30 2017-08-31 2017-05-31 
      
    		                                  
      cash flows from operating activities
    		                                  
      net income available to common shareholders
    		89,346,000 170,908,000 20,209,000 33,603,000 35,419,000 -36,796,000 14,263,000 23,290,000 24,732,000 24,922,000 -2,539,000 -24,142,000                       
      plus: dividends on series a preferred stock
    		  0 0 0 1,200,000                             
      plus: redemption premium on series a preferred stock
    		  0 0 0 75,198,000                             
      net income
    		89,346,000 170,908,000  33,603,000 35,419,000 39,602,000        24,077,000 21,622,000 21,085,000 18,978,000 22,337,000 16,160,000 19,703,000 -1,790,000 5,541,000 -10,643,000 22,035,000 15,558,000 21,284,000 8,851,000 15,395,000 11,244,000 15,718,000 23,487,000 113,000 8,329,000 13,240,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                                  
      bad debt expense
    		-298,000 320,000 5,124,000 -67,000 -329,000 330,000  -26,000 61,000 18,000 -20,000 -37,000   116,000 28,000 -303,000 -218,000                 
      depreciation and amortization
    		22,372,000 21,827,000 20,822,000 20,633,000 20,427,000 20,323,000 20,389,000 20,357,000 20,153,000 18,524,000 18,777,000 21,938,000                       
      deferred income taxes
    		25,190,000 -4,056,000 548,000 2,540,000 1,717,000 3,164,000 4,959,000 2,382,000 -634,000 -2,022,000 27,428,000 1,402,000 -19,101,000 -2,722,000 8,422,000 -4,001,000 -62,000 -892,000 3,099,000 833,000 -3,346,000 -2,147,000 1,869,000 -619,000 -4,535,000 668,000 2,198,000 1,066,000 -172,000 639,000 -22,999,000 1,680,000 -285,000 967,000 
      equity in earnings of unconsolidated entities
    		-59,345,000 -173,523,000 -3,693,000 -7,168,000 -1,478,000 -3,824,000 -4,271,000 -8,742,000 -974,000 -1,420,000 -1,591,000                        
      distribution on investment in avail joint venture
    		0 273,223,000 5,801,000 1,609,000 4,616,000 539,000                             
      restructuring charges
    		0 3,744,000                                 
      net gain on sale of property, plant and equipment
    		88,000 -2,686,000 29,000 90,000 -471,000 -16,000                      117,000 -520,000 212,000     
      amortization of debt financing costs
    		3,220,000 3,198,000 3,154,000 3,140,000 3,110,000 3,109,000 3,066,000 3,043,000 3,033,000 3,029,000                         
      share-based compensation expense
    		4,346,000 5,086,000 2,017,000 3,796,000 4,913,000 2,535,000 3,303,000 2,188,000 2,115,000 1,904,000 1,244,000 2,368,000 2,772,000 1,998,000 2,907,000 1,860,000 2,871,000 1,811,000 1,557,000 1,690,000 2,317,000 1,766,000 1,386,000 1,818,000 1,736,000 1,350,000 1,324,000 -324,000 2,301,000 1,358,000 1,311,000 1,410,000 2,206,000 1,194,000 
      changes in current assets and current liabilities
    		-23,488,000 17,768,000 14,201,000 11,402,000 -16,103,000 7,610,000 15,183,000 17,435,000                           
      changes in other long-term assets and long-term liabilities
    		-3,044,000 -1,027,000 -3,900,000 -3,411,000 -4,335,000 -1,428,000 -45,000 -913,000                           
      net cash from operating activities
    		58,387,000 314,782,000  66,167,000 47,486,000 71,944,000        23,314,000  11,910,000 26,698,000 11,060,000  27,228,000 43,350,000 -11,184,000  33,819,000 56,822,000 -18,587,000  42,928,000 29,833,000 -12,366,000  35,925,000 18,589,000 -15,804,000 
      capex
    		-19,278,000 -20,896,000  -26,441,000 -32,105,000 -27,396,000        -7,809,000  -6,032,000 -5,610,000 -7,489,000  -8,616,000 -8,422,000 -10,847,000  -6,047,000 -11,810,000 -4,686,000  -6,512,000 -4,332,000 -2,847,000  -4,897,000 -6,495,000 -10,141,000 
      free cash flows
    		39,109,000 293,886,000  39,726,000 15,381,000 44,548,000        15,505,000  5,878,000 21,088,000 3,571,000  18,612,000 34,928,000 -22,031,000  27,772,000 45,012,000 -23,273,000  36,416,000 25,501,000 -15,213,000  31,028,000 12,094,000 -25,945,000 
      cash flows from investing activities
    		                                  
      purchase of property, plant and equipment
    		-19,278,000 -20,896,000 -29,941,000 -26,441,000 -32,105,000 -27,396,000 -28,219,000 -24,174,000 -25,690,000 -17,036,000 -22,035,000 -16,389,000 -10,887,000 -7,809,000  -6,032,000 -5,610,000 -7,489,000  -8,616,000 -8,422,000 -10,847,000  -6,047,000 -11,810,000 -4,686,000  -6,512,000 -4,332,000 -2,847,000  -4,897,000 -6,495,000 -10,141,000 
      acquisition of subsidiaries, net of cash acquired
    		          718,000 15,065,000 0 -1,298,513,000         0 -20,704,000 -931,000 -38,993,000 0 0 0 -8,000,000 -11,944,000 -22,591,000   
      proceeds from sale of property, plant and equipment
    		53,000 3,774,000  81,000          33,000  169,000 2,514,000 23,000  57,000    5,000 122,000 210,000  23,000       
      net cash from investing activities
    		-49,369,000 -17,122,000  -26,360,000 -31,361,000 -27,379,000        -1,306,289,000  -5,863,000 -3,096,000 -7,466,000  -4,456,000 316,000 -10,847,000  -26,746,000 -12,619,000 -43,469,000  -6,489,000 -3,993,000 -10,847,000  -27,465,000 -16,739,000 -9,970,000 
      cash flows from financing activities
    		                                  
      proceeds from issuance of common stock
    		  1,226,000 0   899,000 1,000   605,000 0   1,244,000 0   1,138,000 0   1,332,000 0           
      redemption of series a preferred stock
    		    0 -308,920,000                             
      tax payments related to common stock issued under stock-based plans
    		-417,000 -4,598,000                                 
      proceeds from revolving credit facility
    		226,000,000 210,000,000 55,000,000 78,000,000                               
      payments on revolving credit facility
    		-281,000,000 -160,000,000 -65,000,000 -113,000,000                               
      proceeds from receivables securitization facility
    		                                  
      payments of debt financing costs
    		-1,158,000 -20,000 -362,000 -826,000 0 -715,000 -400,000 -96,000   7,000 -4,858,000 4,858,000 -87,555,000                     
      payments on long term debt and finance leases
    		-100,571,000 -335,809,000      -106,000                           
      payments of dividends
    		-6,012,000 -5,085,000 -5,086,000 -5,079,000 -5,076,000 -7,867,000 -7,867,000 -7,864,000 -7,852,000 -7,835,000 -10,075,000 -4,246,000 -4,226,000 -4,192,000  -4,163,000 -4,265,000 -4,245,000  -4,432,000 -4,467,000 -4,425,000  -4,461,000 -4,454,000 -4,440,000  -4,435,000 -4,426,000 -4,418,000  -4,421,000 -4,422,000 -4,423,000 
      net cash from financing activities
    		-11,102,000 -295,512,000  -41,162,000 -24,208,000 -38,542,000        1,368,940,000  -2,819,000 -20,738,000 -5,610,000  -19,098,000 -56,167,000 11,036,000  -5,987,000 -44,364,000 51,560,000  -27,435,000 -30,926,000 16,796,000  -1,755,000 -4,924,000 20,890,000 
      effect of exchange rate changes on cash
    		-62,000 -593,000 372,000 687,000 -311,000 174,000 -45,000 25,000 -704,000 737,000 2,704,000 -4,700,000 2,550,000 -49,000  1,639,000 221,000 -418,000  1,493,000 115,000 722,000  -380,000 158,000 77,000  -795,000 352,000 -498,000  397,000 286,000 -81,000 
      net decrease in cash and cash equivalents
    		                 -2,434,000  5,167,000 -12,386,000 -10,273,000  706,000 -3,000 -10,419,000  8,209,000 -4,734,000 -6,915,000     
      cash and cash equivalents at beginning of period
    		0 1,488,000 0 0 0 4,349,000 0 0 0 2,820,000  0 0 15,082,000  0 0 14,837,000  0 0 36,687,000  0 0 24,005,000  0 0 20,853,000     
      cash and cash equivalents at end of period
    		-2,146,000 3,043,000  -668,000 -8,394,000 10,546,000   -1,770,000 3,878,000  -11,050,000 -86,658,000 100,998,000  4,867,000 3,085,000 12,403,000  5,167,000 -12,386,000 26,414,000  706,000 -3,000 13,586,000  8,209,000 -4,734,000 13,938,000     
      balance at may 31, 2025
    		                                  
      share-based compensation
    		                                  
      common stock issued under stock-based plans and related tax expense
    		  22,000 112,000 -92,000 112,000                             
      common stock issued under employee stock purchase plan
    		  27,000 0                               
      cash dividends paid on common stock
    		                                  
      other comprehensive income
    		                                  
      balance at august 31, 2025
    		                                  
      balance at february 28, 2025
    		                                  
      net increase in cash and cash equivalents
    		 1,555,000 4,000   6,197,000 -3,160,000   1,058,000 -470,000 -11,050,000 -86,658,000 85,916,000  4,867,000                   
      common stock
    		                                  
      shares
    		                                  
      balance at march 31, 2025
    		                                  
      less: net income from discontinued operations
    		          -6,366,000 -38,969,000                       
      net income from continuing operations
    		      17,863,000 26,890,000 28,332,000 28,522,000 7,427,000 18,427,000                       
      adjustments to reconcile net income from continuing operations to net cash from operating activities:
    		                                  
      loss on abandonment of long-lived assets
    		                                  
      net cash from operating activities of continuing operations
    		      63,540,000 62,588,000 71,447,000 46,893,000 22,808,000 26,611,000                       
      proceeds from sale of subsidiaries
    		                                  
      proceeds from sale or insurance settlements of property, plant and equipment
    		          7,000 25,000                       
      net cash from investing activities of continuing operations
    		      -28,211,000 -24,147,000 -25,679,000 -17,027,000 -21,268,000 105,467,000                       
      payments for taxes related to net share settlement of equity awards
    		     -4,567,000 -920,000 0 919,000 -1,710,000 -408,000 -286,000 7,000 -2,313,000 -18,000 -20,000 -48,000 -2,101,000 -66,000 -92,000 -15,000 -539,000 -14,000 -526,000           
      proceeds from long term debt
    		          0 0 0 1,540,000,000                     
      payments on long term debt and finance lease liabilities
    		  -20,299,000 -257,000 -60,236,000 -30,196,000                             
      net cash from financing activities of continuing operations
    		      -38,444,000 -33,065,000 -46,834,000 -29,545,000 21,879,000 -239,640,000                       
      net cash from operating activities from discontinued operations
    		          -29,248,000 -17,125,000                       
      net cash from investing activities from discontinued operations
    		          2,655,000 -1,663,000                       
      net cash from financing activities from discontinued operations
    		          0                        
      net cash from discontinued operations
    		                                  
      cash and cash equivalents from continuing operations at end of period
    		      -3,160,000 5,401,000 -1,770,000 3,878,000  -8,050,000                       
      balance at february 28, 2022
    		                                  
      dividends on series a preferred stock
    		                                  
      cash dividends paid on common shares
    		                                  
      balance at february 28, 2023
    		      24,672,000 0                           
      balance at february 29, 2024
    		  0 0 0 25,102,000                             
      common stock issued
    		                                  
      redemption premium on series a preferred stock
    		                                  
      other comprehensive loss
    		                                  
      redemption of preferred stock
    		                                  
      tax payments related to net share settlement of equity awards
    		   0                               
      balance at august 31, 2024
    		   0                               
      balance at november 30, 2024
    		                                  
      secondary public offering and issuance of additional common stock
    		     4,600,000                             
      balance at may 31, 2024
    		    0 29,814,000                             
      other investing activities
    		     17,000 8,000 27,000 11,000 9,000                         
      proceeds from secondary public offering and issuance of additional common stock
    		     308,723,000                             
      proceeds from revolving loan
    		     75,000,000 60,000,000 47,000,000 50,000,000 92,000,000 125,000,000 80,000,000 136,000,000 39,000,000 80,000,000 34,000,000 147,000,000 35,000,000 67,000,000 65,000,000 20,000,000 76,000,000 108,000,000 101,000,000 32,500,000 187,000,000 52,000,000 34,000,000 75,500,000 102,500,000 76,000,000 64,000,000 81,000,000 128,000,000 
      payments on revolving loan
    		     -70,000,000 -40,000,000 -72,000,000 -90,000,000 -112,000,000 -40,000,000 -97,000,000 -109,000,000 -116,000,000 -45,000,000 -25,000,000 -150,000,000 -28,000,000 -95,000,000 -55,000,000 -67,000,000 -60,000,000 -160,000,000 -102,000,000 -73,500,000 -131,000,000 -84,000,000 -57,000,000 -102,000,000 -67,000,000 -82,000,000 -59,000,000 -79,000,000 -36,500,000 
      net (income) income from discontinued operations
    		                                  
      plus: dividends on preferred stock
    		      3,600,000 3,600,000                           
      other non-cash items
    		                                  
      proceeds from divestiture
    		                                  
      repurchase and retirement of treasury stock
    		               -7,636,000 -14,969,000 -6,264,000                 
      less: cash and cash equivalents from discontinued operations at end of period
    		                                  
      balance at february 28, 2021
    		                                  
      repurchase and retirement of common stock
    		                                  
      dividends on preferred stock
    		                                  
      impairment of long-lived assets
    		           100,000                       
      net (gain) on sale of property, plant and equipment
    		       -26,000 -11,000 -2,000                         
      balance at august 31, 2023
    		       0                           
      dividends paid on common shares
    		                                  
      balance at november 30, 2023
    		                                  
      common stock issued under stock-based plans and related income tax expense
    		                                  
      balance at may 31, 2023
    		                                  
      foreign currency translation
    		                                  
      interest rate swap
    		                                  
      plus: accrued dividends on preferred stock
    		         3,600,000 3,600,000                        
      effects of changes in assets and liabilities, net of acquisitions and dispositions:
    		                                  
      accounts receivable
    		         12,936,000 -10,115,000 19,383,000 -25,188,000 -10,625,000 -15,765,000 -10,934,000 56,000 -7,966,000 -1,789,000 -9,971,000 10,965,000 8,721,000 27,082,000 -18,909,000 5,049,000 -14,228,000 5,824,000 -776,000 16,398,000 -29,577,000 19,246,000 -16,693,000 15,053,000 -14,114,000 
      inventories
    		         -1,198,000 -2,552,000 1,435,000 2,973,000 -19,054,000 -11,168,000 -3,519,000 -4,930,000 -8,254,000 3,908,000 -1,283,000 3,969,000 -4,449,000 19,630,000 -9,305,000 7,869,000 7,681,000 -2,159,000 3,735,000 -809,000 -1,362,000 1,817,000 7,914,000 -11,722,000 -7,936,000 
      prepaid expenses and other
    		         -2,494,000 2,005,000 3,043,000 3,214,000 -12,452,000  3,403,000 2,696,000 -5,419,000  955,000 2,313,000 -941,000  3,546,000 -815,000 -1,240,000  1,437,000 3,537,000 -5,927,000  1,503,000 1,598,000 -5,619,000 
      other assets
    		         43,000 273,000 304,000 -4,554,000 300,000  46,000 -1,827,000 -778,000  24,000 79,000 123,000  -82,000 183,000 185,000  11,000 131,000 -1,148,000  1,049,000 -87,000 -1,019,000 
      net change in contract assets and liabilities
    		         -1,949,000 -6,814,000 10,161,000 4,938,000 -12,689,000 22,937,000 -5,648,000 4,768,000 -9,839,000 20,434,000 -14,845,000 -3,620,000 3,168,000 7,109,000 -4,197,000 5,136,000 -55,088,000 12,587,000 9,782,000 1,160,000 -20,438,000     
      accounts payable
    		         -2,665,000 1,087,000 -47,962,000 -8,739,000 41,579,000 813,000 -2,190,000 -3,660,000 6,321,000 -13,739,000 8,149,000 -603,000 -15,328,000 -7,792,000 5,377,000 5,941,000 7,068,000 7,866,000 1,988,000 -15,601,000 5,576,000 7,407,000 903,000 -4,365,000 -2,405,000 
      other accrued liabilities and income taxes payable
    		         -6,333,000 -19,945,000 -5,561,000 26,412,000 -3,464,000 -6,134,000 115,000 -3,579,000 2,749,000 -11,425,000 8,946,000 2,884,000 -19,610,000 -5,429,000 21,256,000 8,854,000 -1,145,000 8,081,000 -1,925,000 -1,714,000 7,559,000 -1,993,000 -7,540,000 276,000 -1,927,000 
      cash from discontinued operations
    		          -26,593,000 101,212,000                       
      other operating cash payments
    		                                  
      cash paid for interest
    		         25,866,000    4,161,000 2,407,000 351,000 2,910,000 394,000 3,758,000 435,000 3,937,000 869,000 4,597,000 1,607,000 5,219,000 1,600,000 4,923,000 2,119,000 5,373,000 2,465,000 4,645,000 1,928,000 4,734,000 2,286,000 
      cash paid for income taxes
    		         895,000    4,034,000 8,401,000 8,899,000 13,038,000 1,322,000 910,000 5,850,000 9,347,000 11,000 10,817,000 4,215,000 3,203,000 567,000 893,000 884,000 844,000 670,000 285,000 811,000 508,000 7,097,000 
      supplemental disclosures of non-cash investing and financing activities
    		                                  
      accrued dividends on preferred stock
    		         2,400,000                         
      accruals for capital expenditures
    		         2,409,000                         
      loss on disposal of business
    		              0    30,000 1,852,000               
      net (gain) loss on sale of property, plant and equipment
    		          349,000 1,361,000 -2,713,000 -29,000  -247,000 500,000 -15,000    40,000   -106,000 -200,000         
      payments on long term debt
    		          -53,250,000 -213,250,000                0 0 -14,286,000  -1,000 0 -63,504,000 
      cash and cash equivalents at beginning of year
    		                                  
      cash and cash equivalents at end of year
    		                                  
      less: cash and cash equivalents from discontinued operations at end of year
    		                                  
      cash and cash equivalents from continuing operations at end of year
    		                                  
      amortization of deferred borrowing costs
    		           1,255,000 3,120,000 1,541,000  221,000 191,000 139,000  234,000 134,000 135,000  135,000 133,000 136,000  64,000 205,000 138,000  147,000 149,000 154,000 
      bad debt recoveries
    		             -265,000                     
      amortization and depreciation
    		             15,119,000  11,139,000 10,999,000 11,084,000  11,027,000 11,481,000 11,668,000  12,624,000 12,258,000 12,326,000  12,370,000 12,627,000 13,071,000  12,856,000 12,561,000 12,423,000 
      supplemental disclosures
    		                                  
      cash flows from operating activities:
    		                                  
      gain on disposal group held for sale
    		                                  
      inventory write-downs
    		                                  
      impairment loss on long lived assets
    		                                  
      gain on sale of property, plant & equipment
    		                                  
      amortization of deferred debt issuance costs
    		                                  
      effects of changes in operating assets and liabilities, net of acquisitions:
    		                                  
      prepaid expenses and other assets
    		                                  
      net cash from operating activities:
    		                                  
      cash flows from investing activities:
    		                                  
      proceeds from the sale or insurance settlement of property, plant, and equipment
    		                                  
      proceeds from sale of subsidiary
    		                                  
      purchases of property, plant and equipment
    		                                  
      net cash from investing activities:
    		                                  
      cash flows from financing activities:
    		                                  
      proceeds from long-term debt
    		                                  
      payments on long-term debt
    		                                  
      debt issuance costs paid
    		                                  
      payment of dividends
    		                                  
      net cash from financing activities:
    		                                  
      effect of exchange rate changes on cash and cash equivalents
    		                                  
      net change in cash and cash equivalents
    		                                  
      cash and cash equivalents, beginning of year
    		                                  
      cash and cash equivalents, end of year
    		                                  
      supplemental disclosures of cash flow information:
    		                                  
      loss on disposal group held for sale
    		                                  
      non-cash restructuring and impairment charges
    		                   -206,000               
      loss on sale of property, plant & equipment
    		                                  
      benefit from doubtful accounts
    		                   7,000 97,000 129,000 418,000 139,000 -439,000 2,616,000 114,000 -11,000 235,000 1,815,000 67,000 2,893,000   
      purchases of treasury shares
    		                   -24,574,000           0 -2,333,000 -2,502,000 -2,683,000 
      effects of changes in assets and liabilities, net of acquisitions:
    		                                  
      net income on property, plant and equipment due to impairment
    		                           -1,000       
      net income on disposition of property, plant & equipment due to impairment
    		                                  
      net income on sale of property, plant & equipment and insurance proceeds
    		                                  
      effects of changes in assets and liabilities:
    		                                  
      net (gain) loss on sale of property, plant & equipment and insurance proceeds
    		                                  
      net change in billings related to costs and estimated earnings on uncompleted contracts
    		                              -3,912,000 21,383,000 -5,762,000 -10,725,000 
      excess tax benefits from share-based compensation
    		                                  
      net income on disposition of property, plant and equipment due to impairment
    		                                  
      net income on sale of property, plant and equipment and insurance proceeds
    		                                  
      proceeds from sale or insurance settlement of property, plant and equipment
    		                                  
      net income on disposition of property, plant & equipment due to realignment
    		                                  
      effects of changes in assets & liabilities:
    		                                  
      proceeds from sale or insurance settlement of property, plant, and equipment
    		                                6,000 171,000 
      net decrease in cash & cash equivalents
    		                                -2,788,000 -4,965,000 
      cash & cash equivalents at beginning of period
    		                                0 11,302,000 
      cash & cash equivalents at end of period
    		                                -2,788,000 6,337,000 
      provision (recovery) for doubtful accounts
    		                                 63,000 
      net gain on sale of property, plant & equipment and insurance proceeds
    		                                 -100,000 
      debt acquisition costs
    		                                  
      proceeds from exercise of stock options and stock appreciation rights
    		                                  
      excess tax benefits from stock options and stock appreciation rights
    		                                  
      depreciation
    		                                  
      amortization
    		                                  
      non-cash compensation expense
    		                                  
      non-cash interest expense
    		                                  
      deferred income tax expense
    		                                  
      net (gain) loss on insurance settlement or sale of property, plant and equipment
    		                                  
      effects of changes in operating assets and liabilities, net of business acquisitions:
    		                                  
      other accrued liabilities and income taxes
    		                                  
      proceeds from the sale or insurance settlement of property, plant and equipment
    		                                  
      debt origination costs
    		                                  
      tax benefits from stock options exercised
    		                                  
      cash dividends paid
    		                                  
      cash paid during the year for:
    		                                  
      interest
    		                                  
      income taxes
    		                                  
      proceeds on revolving loan
    		                                  
      proceeds from settlement of derivative
    		                                  
      net gain on insurance settlement or sale of property, plant and equipment
    		                                  
      share based compensation expense
    		                                  
      cumulative effect of change in accounting principle
    		                                  
      proceeds from exercise of stock options
    		                                  
      effects of changes in operating assets and liabilities:
    		                                  
      proceeds from the sale of property, plant and equipment
    		                                  
      effects of changes in operating assets and liabilities, net of acquisition of subsidiaries:
    		                                  
      proceeds from the sale of long-term investments
    		                                  
      purchase of treasury stock
    		                                  
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.